HomeNewsBusinessCompaniesAurobindo gets final US FDA nod for hypertension drug
Trending Topics
Sensex Live
IPO Allotment Status Live
Wakefit IPO Allotment
KSH International IPO
Gold Rate Today

Aurobindo gets final US FDA nod for hypertension drug

Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension.

June 10, 2011 / 15:41 IST
Story continues below Advertisement
Remove Ad

Moneycontrol Bureau

Aurobindo Pharma has received final approval from the US Food and Drugs Administration to manufacture and market Ramipril capsules, which are used for the treatment of hypertension. Aurobindo
first published: Jun 10, 2011 01:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Ind vs SA T20 Live Score IPO Allotment Status Live Wakefit IPO Allotment Status US Gold Card Karnataka hate speech bill Goa night club fire Meesho Share Price Amit Shah TDS on Rent
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.